Tvax Biomedical LLC
TVAX Biomedical LLC, based in Olathe, KS, is at the forefront of cancer treatment innovation with its novel TVAX Immunotherapy approach. This personalized T cell therapy utilizes killer T cells derived from patients' blood to enhance immune responses against various types of cancer, aiming for improved clinical outcomes with low toxicity.
Currently, the company is advancing its lead product candidate, TVI-Brain-1, which targets glioblastoma and has received Fast Track Designation from the FDA for its pivotal phase 2b clinical trial. TVAX Biomedical is dedicated to revolutionizing cancer care and improving the lives of patients through its cutting-edge therapies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.



